Weight Loss Patients Thrive on Fewer GLP-1 Injections

The question weighing on millions of Americans considering weight loss drugs just got a hopeful answer: you might not need weekly injections forever.

A new study from Scripps Clinic in San Diego found that 34 patients who had already lost weight on GLP-1 medications like Wegovy and Ozempic successfully maintained their progress while taking injections less frequently. Most either kept their weight steady or continued losing small amounts, even when stretching doses to every two weeks or longer.

Dr. Mitch Biermann, an obesity specialist, noticed the pattern after patients started telling him they'd spaced out their injections on their own. "By the time the third person told me they were taking it every second or third week and still maintaining their weight, I started recommending it to other patients," he told The New York Times.

After 36 weeks of follow-up, the results held strong. Blood pressure and blood sugar levels continued improving, and any additional weight lost came from fat rather than muscle. Only four patients gained weight back and returned to weekly injections.

Scott McMillin, 65, experienced this firsthand. After losing 20 pounds on weekly Wegovy and improving his blood pressure and cholesterol, he tried spacing injections to every two weeks. "It made no difference for me whether I was taking injections every week or every two weeks, and I just thought, well, less is better," he said.

Participants used different schedules based on what worked for them. Seventeen took injections every other week, six stretched to every 10 to 14 days, and seven went beyond two weeks, with one patient reaching six weeks between doses.

The Bright Side

This research arrives at a crucial moment. Only about 6% of Americans currently use GLP-1 drugs, even though roughly 51% of adults meet eligibility criteria. Cost and the prospect of lifelong weekly injections keep many people from starting treatment.

"The number one question patients give me about this drug is, 'Will I have to take this every week forever?'" Biermann said. This study suggests the answer might be no.

Dr. Fatima Stanford from Harvard Medical School says the findings "reframe the conversation" around weight loss medication. "Chronic treatment does not necessarily mean maximal weekly dosing forever," she explained. Individualized dosing plans that adjust to each person's needs may prove more effective than one-size-fits-all approaches.

The study was small and looked at patients who were mostly white and privately insured, so results may vary for different populations. Researchers also emphasized that patients didn't stop medication entirely—they simply reduced frequency after reaching their weight loss goals.

For people worried about the commitment of weight loss drugs, this research offers a promising path forward: effective treatment that adapts to your life, not the other way around.